BD - Earth day 2024
AmericanHHM
KP - Pentamed® - High performance packaging films for medical devices

ExtriCARE USA Unveils the ExtriCARE 1000 NPWT System

Wednesday, March 20, 2024

ExtriCARE USA is excited to introduce the ExtriCARE 1000 Negative Pressure Wound Therapy (NPWT) System. This state-of-the-art device represents a significant leap forward in NPWT technology, seamlessly combining lightweight design and powerful functionality to address the diverse needs of patients and healthcare providers alike.

The ExtriCARE 1000 offers a personalized approach to wound care, featuring three pressure settings and two operational modes (continuous or intermittent). This versatility enables healthcare professionals to tailor treatment plans according to individual patient requirements, ensuring optimal care for a wide range of wound types, particularly closed incisional wounds.

Equipped with a 50cc canister, the ExtriCARE 1000 efficiently manages exudate, minimizing the risk of complications such as pooling or skin maceration. By effectively controlling exudate, the device promotes healing and enhances patient comfort throughout the treatment process.

Designed with patient comfort and mobility in mind, the ExtriCARE 1000 features a compact and lightweight design, weighing just 0.5 lbs. This portability makes it easy to use in various care settings, allowing for seamless integration into patient care routines without compromising on performance.

The ExtriCARE 1000 provides continuous support without time restrictions, reflecting our commitment to delivering enduring value in wound care management. This ensures that patients receive consistent and reliable treatment throughout their healing journey. Utilizing ExtriCARE's hybrid NPWT (hNPWT) philosophy, the ExtriCARE 1000 combines the best features of traditional and single-use NPWT systems. This innovative approach offers a continuum of care that can significantly improve healing outcomes for patients.

With FDA clearance and CE certification pending in Europe, the ExtriCARE 1000 meets the highest regulatory standards for safety and effectiveness. This makes it suitable for use in healthcare settings worldwide, providing healthcare providers with confidence in its reliability and performance.

In summary, the ExtriCARE 1000 NPWT System represents a significant advancement in wound care technology. With its personalized treatment options, efficient exudate management, enhanced mobility, continuous support, and innovative hybrid approach, it is poised to redefine the standard of care for patients with various wound types.

Source: prnewswire.com

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CMO SummitHealthcare CFO, Financial Strategy & Revenue Cycle SummitThe Healthcare Patient Experience & Engagement Summit 2024Healthcare Innovation & Transformation SummitHealthcare CEO & Executive Strategy SummitHealthcare CNO Summit